“We might be able to have a big impact.” Since January 2023, two new drug treatments — Leqembi made by Eisai and Biogen and Kisunla made by Eli Lilly — have been approved by the Food and ...
its drug for Alzheimer's disease, providing patients with another treatment option after Eisai (4523.T), opens new tab and Biogen's (BIIB.O), opens new tab Leqembi received the nod in September ...